Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada

Search

Controlled Drugs and Substances Act (S.C. 1996, c. 19)

Act current to 2025-02-17 and last amended on 2024-09-03. Previous Versions

SCHEDULE III(Sections 2, 4 to 7.1, 10, 29, 55 and 60)

  • 1 
    [Repealed, 2012, c. 1, s. 45]
  • 2 
    Methylphenidate (methyl 2-phenyl-2-(piperidin-2-yl)acetate), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including
    • (1) 
      Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)
    • (2) 
      Isopropylphenidate (isopropyl 2-phenyl-2-(piperidin-2-yl)acetate)
    • (3) 
      Propylphenidate (propyl 2-phenyl-2-(piperidin-2-yl)acetate)
    • (4) 
      3,4-Dichloromethylphenidate (methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate)
    • (5) 
      4-Methylmethylphenidate (methyl 2-(4-methylphenyl)-2-(piperidin-2-yl)acetate)
    • (6) 
      4-Fluoromethylphenidate (methyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate)
    • (7) 
      Methylnaphthidate (methyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate)
    • (8) 
      Ethylnaphthidate (ethyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate)
  • 3 
    Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof
  • 4 
    Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof
  • 5 
    Lysergic acid diethylamide (LSD) (N,N–diethyllysergamide) and any salt thereof
  • 6 
    N,N–Diethyltryptamine (DET) (3–[(2–diethylamino) ethyl]indole) and any salt thereof
  • 7 
    N,N–Dimethyltryptamine (DMT) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof
  • 8 
    N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof
  • 9 
    Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof
  • 10 
    Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof
  • 11 
    Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof
  • 12 
    Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof
  • 13 
    N–(1–phenylcyclohexyl)ethylamine (PCE) and any salt thereof
  • 14 
    1–[1–(2–Thienyl) cyclohexyl]piperidine (TCP) and any salt thereof
  • 15 
    1–Phenyl–N–propylcyclohexanamine and any salt thereof
  • 16 
    Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof
  • 17 
    Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora)
  • 18 
    [Repealed, SOR/2017-249, s. 1]
  • 19 
    Cathinone ((-)-α-aminopropiophenone) and its salts
  • 20 
    Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof
  • 21 
    2–Methylamino–1–phenyl–1–propanone and any salt thereof
  • 22 
    1–[1–(Phenylmethyl)cyclohexyl]piperidine and any salt thereof
  • 23 
    1–[1–(4–Methylphenyl)cyclohexyl]piperidine and any salt thereof
  • 24 
    [Repealed, SOR/2016-73, s. 1]
  • 25 and 26 
    [Repealed, 2012, c. 1, s. 46]
  • 27 
    Aminorex (5-phenyl-4,5-dihydro-1,3-oxazol-2-amine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including
    • (1) 
      4-Methylaminorex (4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine)
    • (2) 
      4,4’-Dimethylaminorex (4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)
  • 28 
    Etryptamine (3-(2-aminobutyl)indole) and any salt thereof
  • 29 
    Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers
  • 30 
    Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof
  • 31 
    Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof
  • 32 
    Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof
  • 33 
    Benzylpiperazine [BZP], namely 1-benzylpiperazine and its salts, isomers and salts of isomers
  • 34 
    Trifluoromethylphenylpiperazine [TFMPP], namely 1-(3-trifluoromethylphenyl)piperazine and its salts, isomers and salts of isomers
  • 35 
    2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers that correspond to the following chemical description :
    • any substance that has a 1-amino-2-phenylethane structure substituted at the 2’ and 5’ or 2’ and 6’ positions of the benzene ring by an alkoxy or haloalkoxy group, or substituted at two adjacent carbon atoms of the benzene ring which results in the formation of a furan, dihydrofuran, pyran, dihydropyran or methylenedioxy group — whether or not further substituted on the benzene ring to any extent, whether or not substituted at the amino group by one or two, or a combination of, methyl, ethyl, propyl, isopropyl, hydroxyl, benzyl (or benzyl substituted to any extent) or benzylene (or benzylene substituted to any extent) groups and whether or not substituted at the 2-ethyl (beta carbon) position by a hydroxyl, oxo or alkoxy group — and its salts and derivatives and salts of derivatives, including
      • (1) 
        4-bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe)
      • (2) 
        4-chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25C-NBOMe)
      • (3) 
        4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe)
      • (4) 
        4-bromo-2,5-dimethoxybenzeneethanamine (2C-B)
  • 1996, c. 19, Sch. III
  • SOR/97-230, ss. 7 to 10
  • SOR/98-173, s. 1
  • SOR/2000-220, s. 1
  • SOR/2003-32, ss. 2, 3, 4(F), 5
  • SOR/2003-412
  • SOR/2005-235, s. 2
  • 2012, c. 1, ss. 45, 46
  • SOR/2012-66
  • SOR/2016-73
  • SOR/2016-107, s. 2
  • 2017, c. 7, s. 48
  • SOR/2017-13, s. 6
  • SOR/2017-44, 249
Previous Version

Table of Contents

 

Date modified: